NEXUS AG (NXU.DE) Stock Price & Overview
FRA:NXU • DE0005220909
Current stock price
The current stock price of NXU.DE is 71.2 EUR. Today NXU.DE is down by -0.14%. In the past month the price increased by 0.28%. In the past year, price increased by 4.09%.
NXU.DE Key Statistics
- Market Cap
- 1.23B
- P/E
- 36.14
- Fwd P/E
- 32.24
- EPS (TTM)
- 1.97
- Dividend Yield
- 0.32%
NXU.DE Stock Performance
NXU.DE Stock Chart
NXU.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to NXU.DE. When comparing the yearly performance of all stocks, NXU.DE turns out to be only a medium performer in the overall market: it outperformed 44.11% of all stocks.
NXU.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to NXU.DE. Both the health and profitability get an excellent rating, making NXU.DE a very profitable company, without any liquidiy or solvency issues.
NXU.DE Earnings
NXU.DE Forecast & Estimates
7 analysts have analysed NXU.DE and the average price target is 71.4 EUR. This implies a price increase of 0.28% is expected in the next year compared to the current price of 71.2.
For the next year, analysts expect an EPS growth of 14.6% and a revenue growth 9.04% for NXU.DE
NXU.DE Groups
Sector & Classification
NXU.DE Financial Highlights
Over the last trailing twelve months NXU.DE reported a non-GAAP Earnings per Share(EPS) of 1.97. The EPS increased by 26.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.11% | ||
| ROA | 6.93% | ||
| ROE | 11.27% | ||
| Debt/Equity | 0.05 |
NXU.DE Ownership
NXU.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EQS | EQUASENS | 13.49 | 643.967M | ||
| GPI | GPI SPA | 17.5 | 470.655M | ||
| ALMDT | MEDIAN TECHNOLOGIES | N/A | 182.274M | ||
| ALCGM | CEGEDIM SA | 7.09 | 170.61M | ||
| AGFB | AGFA-GEVAERT NV | 15.72 | 75.397M | ||
| AJ91 | DOCCHECK AG | N/A | 62.868M | ||
| M3V | MEVIS MEDICAL SOLUTIONS AG | N/A | 41.496M | ||
| ALINS | INTRASENSE SAS | N/A | 10.808M | ||
| MLLAB | MEDIA LAB SPA | N/A |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About NXU.DE
Company Profile
NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,971 full-time employees. The company went IPO on 2000-07-24. The firm is engaged in the development, trade and service of software solutions for facilities of the healthcare system. The company is divided into three divisions: NEXUS/ DE (Germany), NEXUS/ DIS (Diagnostic systems) and NEXUS/ ROE (Rest of Europe). The firm has different product groups such as: NEXUS/ HISng, an information system for somatic hospitals in Germany; NEXUS/ PSYCHIATRY, an information system for psychiatric institutions; NEXUS/ REHAng, an information system for rehabilitation facilities; NEXUS/ ITR, a software for rehabilitation, private, acute care clinics not providing surgery and hotels with medical care; NEXUS/ ARCHIVE and NEXUS/ PEGASOS, provides archiving and process management in healthcare, among others.
Company Info
IPO: 2000-07-24
NEXUS AG
Irmastrasse 1
Donaueschingen BADEN-WUERTTEMBERG DE
Employees: 1909
Phone: 49771229600
NEXUS AG / NXU.DE FAQ
Can you describe the business of NEXUS AG?
NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,971 full-time employees. The company went IPO on 2000-07-24. The firm is engaged in the development, trade and service of software solutions for facilities of the healthcare system. The company is divided into three divisions: NEXUS/ DE (Germany), NEXUS/ DIS (Diagnostic systems) and NEXUS/ ROE (Rest of Europe). The firm has different product groups such as: NEXUS/ HISng, an information system for somatic hospitals in Germany; NEXUS/ PSYCHIATRY, an information system for psychiatric institutions; NEXUS/ REHAng, an information system for rehabilitation facilities; NEXUS/ ITR, a software for rehabilitation, private, acute care clinics not providing surgery and hotels with medical care; NEXUS/ ARCHIVE and NEXUS/ PEGASOS, provides archiving and process management in healthcare, among others.
What is the current price of NXU stock?
The current stock price of NXU.DE is 71.2 EUR. The price decreased by -0.14% in the last trading session.
Does NXU stock pay dividends?
NEXUS AG (NXU.DE) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.22.
What is the ChartMill rating of NEXUS AG stock?
NXU.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Where is NEXUS AG (NXU.DE) stock traded?
NXU.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is NEXUS AG worth?
NEXUS AG (NXU.DE) has a market capitalization of 1.23B EUR. This makes NXU.DE a Small Cap stock.
What is the next earnings date for NXU stock?
NEXUS AG (NXU.DE) will report earnings on 2026-03-02, after the market close.